A carregar...
Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231
Doxorubicin is a commonly used drug to treat various types of cancers. Unfortunately, after a period of administration, tumour cells develop resistance generally under the form of an accelerated drug extrusion. Recently, cell penetrating peptides have been used for their ability to deliver non-perme...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kluwer Academic/Plenum Publishers
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2820506/ https://ncbi.nlm.nih.gov/pubmed/19083085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-008-9782-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|